Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01314651 · ClinicalTrials.gov registry record · NA

Efficacy of Behavioral Insomnia Treatment for Chronic Migraine

A NA study of Insomnia and Chronic Migraine, sponsored by Daniel Riche.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT01314651: Completed NA study of Insomnia and Chronic Migraine, sponsored by Daniel Riche.

NCT01314651 is a NA study of Insomnia and Chronic Migraine that has completed, run by Daniel Riche. The registered enrollment target is 31 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01314651, a NA study of Insomnia and Chronic Migraine, has completed, sponsored by Daniel Riche.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the efficacy of a brief behavioral insomnia intervention in reducing headache frequency and severity among patients with chronic migraine and insomnia. It is hypothesized that this intervention will produce greater changes in headache frequency and severity than will a comparison treatment involving non-sleep-specific general lifestyle modifications.

Interventions

  • BEHAVIORAL Lifestyle Modification
  • BEHAVIORAL Stimulus Control and Sleep Restriction

Study Locations (1)

Mississippi

  • Psychological Services Center - University

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2011-03
Est. Completion 2013-12
Phase NA
Daniel Riche

1 total trials

What the finished NCT01314651 record still lists

NCT01314651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Modification is the first listed.

NCT01314651 reports a single indexed study location in Mississippi.

Frequently Asked Questions

What is clinical trial NCT01314651 about?

NCT01314651 is a clinical study titled "Efficacy of Behavioral Insomnia Treatment for Chronic Migraine". The purpose of this study is to test the efficacy of a brief behavioral insomnia intervention in reducing headache frequency and severity among patients with chronic migraine and insomnia. It is hypothesized that this intervention will produce greater changes in headache frequency and severity than ...

What is the current status of trial NCT01314651?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2011-03. Estimated completion is 2013-12.

What conditions does trial NCT01314651 study?

This clinical trial studies the following conditions: Insomnia, Chronic Migraine.

What interventions are being tested in trial NCT01314651?

The interventions under investigation include: Lifestyle Modification (BEHAVIORAL), Stimulus Control and Sleep Restriction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01314651?

This trial is sponsored by Daniel Riche, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01314651 being conducted?

This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01314651's enrollment target sits among peer trials

31 121st of 151 higher than 31 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01314651, the US trial registry maintained by the National Library of Medicine. NCT01314651 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.